Trial intelligence / Profile preview

ET-50: Sitting Time After Spinal Anesthesia

NCT01561274Phase 2Completed

Sponsor
McGill University Health Centre
Start
Mar 2012
Primary completion
Mar 2014
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, randomised, single-blind trial of bupivacaine in pain (2 arms), sponsored by McGill University Health Centre. Primary endpoint: Estimated Time for 50% of patients to have hypotension up to 20 minutes. Started Mar 2012; status: completed.

02

Drugs

bupivacaine
03

Conditions

pain

Beyond the preview

Go deeper on NCT01561274.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01561274.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call